Над 4 милиона заглавия на английски и други езици! Открийте новата си история още днес! Безплатна доставка за поръчки над 69.99€

Проверка на състоянието на поръчката

Станете част от общност от любители на книгите от цял свят и получавате много предимства. Създай на безплатен акаунт

Безплатна доставка със Еконт над 69.99 €

Куриер Speedy 3.49 € Пункт на Speedy 3.49 € ЕКОНТ 3.99 € Еконтомат/Офис на Еконт 3.99 € Ekont Box 3.99 € Sameday 3.99 € Sameday box 3.99 € Box Now 3.99 €

Контакт

Как се пазарува?

Помощ

Моят акаунт

▸ Празна :-(

Psychedelic Harm Reduction

Name: Psychedelic Harm Reduction
Brand: Springer, Berlin
SKU: 51248624
Price: 184.33 EUR
Availability: InStock
Author: Tomislav Majic
ISBN: 9783032211064

DE

Tomislav Majic

Език

Английски език

Книга С твърди корици

Код Либристо: 51248624

Издателство Springer, Berlin, юли 2026

Scientific interest in classic psychedelics such as psilocybin, LSD, and 5-MeO-DMT has resurged, wit... Цялото описание

Код Либристо: 51248624

446 b

Нови

184.33 €

360.52 лв

Външен склад Изпращаме след 10-13 дни

30 дни за връщане на стоката

Клиентите са закупили също

Prüfung Express - Goethe Zertifikat C1, Deutschprüfung für Erwachsene Christine Kramel

Книга

14.22 € 27.81 лв

Manuel de laboratoire sur les moteurs ? combustion interne Mohammad Ali Shariati

С меки корици

47.11 € 92.15 лв

Python 3 et Machine Learning - Coffret de 2 livres : Théorie et pratique (2e édition) CHAZALLET

С меки корици

96.20 € 188.14 лв

Purées ou morceaux ? Loubet

С твърди корици

17.79 € 34.79 лв

Die geilste Lücke im Lebenslauf Nick Martin

С меки корици

13.44 € 26.29 лв

Scientific interest in classic psychedelics such as psilocybin, LSD, and 5-MeO-DMT has resurged, with promising results for the treatment of mental health conditions including depression, anxiety, and substance use disorders. At the same time, public interest in those substances has increased, giving rise to what has been labelled as a "psychedelic renaissance". Although it has been repeatedly emphasized that psychedelics are not addictive and exhibit very low toxicity, their use is nevertheless associated a range of rare, but considerable risks and potential harms which may even occur after sporadic use. To date, these risks to date remain underrecognized and underresearched, and many clinical psychiatrists and psychologist are insufficiently informed about their pathophysiology, differential diagnosis and clinical management. This book addresses this gap by providing health care professionals and researchers with foundational information on the diverse risks and adverse effects associated with the use of classic psychedelics.

The chapter "Classifying Psychedelic-Related Complications" is available open access under the Creative Commons AttributionNonCommercial-NoDerivatives 4.0 International License via link.springer.com.